Phase Forward Buys Clarix

Phase Forward (NASDAQ: PFWD), a Waltham, MA-based company whose software is used by large pharmaceutical companies and research institutions to manage the huge amounts of data generated by clinical drug trials, said today that it has acquired Clarix of Radnor, PA, for $40 million in cash. Clarix makes hybrid phone- and Web-based interactive voice response systems that help the organizers of drug trials to manage drug supplies at trial sites.

Wade Roush is a freelance science and technology journalist and the producer and host of the podcast Soonish. Follow @soonishpodcast

Trending on Xconomy